Glycine prices in the US market were steady in the first half of November after a -2.3% drop in October. The early November stability was due to a more balanced market as buyers were buying in measured amounts, using up their inventories and matching purchases to immediate production needs in feed, nutraceutical and pharma sectors. Stable imports from Asia and Houston port operations ensured supply was uninterrupted and Glycine was not further pressured down. In October, Glycine CFR Houston fell due to reduced Chinese exports, lower freight and normalized inventories post Q3 drawdowns. These factors set the stage for early November stability with distributors managing their stocks and downstream industries steady offtake. According to market sources, Glycine prices are expected to bounce back and rise slightly in the second half of November. Renewed procurement ahead of year end production cycles, improving demand from feed and pharma sectors and tighter inventories will support a moderate recovery and improve market sentiment and transaction volumes across the US amino acid market.
